<p class="frontmatter-fieldnotes disclaimernew" style="margin-bottom:15px;">This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s <a href="/pages/termsofuse.aspx" target="_blank">Terms & Conditions</a>.</p>
<div id="_idContainer000">
<p class="ltrs-br-ltr-br-title"><span class="bold">Resolution of Suicidal Ideation With Corticosteroids in a Patient With Concurrent Addison’s Disease and Depression</span></p>
<p class="ltrs-br-ltr-br-body-text"><span class="semibold">To the Editor:</span> Neuropsychiatric disturbances in Addison’s disease are often reported,<span class="htm-cite"><a href="#ref1">1–11</a></span> but rarely recognized in clinical practice.<span class="htm-cite"><a href="#ref9">9</a></span> Neuropsychiatric manifestations may often be the initial or sole presenting symptom in many cases of Addison’s disease.<span class="htm-cite"><a href="#ref4">4–8</a>,<a href="#ref10">10</a>,<a href="#ref11">11</a></span> We report a case of concurrent severe depression and Addison’s disease in which depressive symptoms resolved after a single administration of high-dose corticosteroids.</p>
<p class="ltrs-br-ltr-br-body-text"> </p>
<p class="ltrs-br-ltr-br-body-text"><span class="semibold-ital">Case report.</span> Ms A, a 70-year-old woman with atrial fibrillation, hypertension, diabetes mellitus type II, depression, and adrenal hyperplasia status post–bilateral adrenalectomies, developed postoperative Addison’s disease requiring maintenance corticosteroids and presented with several months of generalized weakness, failure to thrive, and poor oral intake. Her symptoms were attributed to inadequate treatment of adrenal insufficiency. In addition, she reported worsening depression in the months preceding her hospital admission, with symptoms of helplessness, poor appetite, psychomotor retardation, hypersomnia, and poor concentration, as well as suicidal ideation. The psychiatry consult-liaison service evaluated Ms A and diagnosed her with depression per <span class="italic">DSM-IV</span> criteria; they planned to initiate venlafaxine. Prior to administration of the venlafaxine, Ms A received a single dose of dexamethasone 8 mg intravenous and hydrocortisone 20 mg intravenous, which led to rapid improvement in her depression. She reported remission of her depression with management of the adrenal insufficiency. Consequently, venlafaxine was not initiated.</p>
<p class="ltrs-br-ltr-br-body-text"> </p>
<p class="ltrs-br-ltr-br-body-text">Addison’s disease is characterized by adrenal insufficiency due to reduced secretion of glucocorticoid by the adrenal glands.<span class="htm-cite"><a href="#ref9">9</a>,<a href="#ref12">12</a></span> Patients often present with chronic progressive fatigue, generalized weakness, loss of appetite, weight loss, and hypotension. The link between neuropsychiatric disturbance and Addison’s disease has been well-reported in the literature,<span class="htm-cite"><a href="#ref1">1–11</a></span> including by Thomas Addison in 1855, who described “attacks of giddiness, anxiety in the face, and delirium” as characteristics of the disease.<span class="htm-cite"><a href="#ref9">9</a></span> The prevalence of neuropsychiatric symptoms in Addison’s disease is estimated to be between 64% and 84%,<span class="htm-cite"><a href="#ref9">9</a></span> and in many cases, neuropsychiatric symptoms may be the initial or sole manifestation.<span class="htm-cite"><a href="#ref4">4–8</a>,<a href="#ref10">10</a>,<a href="#ref11">11</a></span></p>
<p class="ltrs-br-ltr-br-body-text">Multiple theories exist to explain how hypoadrenocorticism may precipitate neuropsychiatric disturbance.<span class="htm-cite"><a href="#ref1">1</a>,<a href="#ref3">3</a>,<a href="#ref9">9</a>,<a href="#ref13">13–15</a></span> Adrenal insufficiency causes electrolyte and metabolic abnormalities,<span class="htm-cite"><a href="#ref9">9</a>,<a href="#ref15">15</a></span> including hyponatremia, which may lead to cerebral edema with encephalopathy.<span class="htm-cite"><a href="#ref15">15</a></span> Adrenal insufficiency may also alter the electrical circuitry of the brain, as evidenced by electroencephalographic changes of diffuse slowing or bursts of activity with no cortical focus seen.<span class="htm-cite"><a href="#ref9">9</a></span> Finally, cortisol binds to receptors in the hippocampus that promote cognition, memory, and enhanced mood. Thus, lack of cortisol can lead to symptoms of depression.<span class="htm-cite"><a href="#ref16">16</a></span> The role of cortisol has been further supported by the finding of relative corticosteroid resistance in depressed patients.<span class="htm-cite"><a href="#ref14">14</a></span></p>
<p class="ltrs-br-ltr-br-body-text">To the authors’ knowledge, this is the first report of corticosteroids acutely improving depression in the setting of Addison’s disease. Previous case reports have described concurrent use of electroconvulsive therapy and corticosteroids to treat Addison’s disease; however, there are no reports of corticosteroids alone as a possible treatment modality.<span class="htm-cite"><a href="#ref17">17</a>,<a href="#ref18">18</a></span></p>
<p class="ltrs-br-ltr-br-body-text">Although the case suggests that corticosteroids may be of some benefit in treating depression with suicidal thoughts in the setting of adrenal insufficiency, the exact role remains unclear, especially for long-term treatment, warranting further investigation.</p>
<p class="ltrs-br-ltr-br-references-head"><span class="smallcaps">References</span></p>
<p class="references-references-text-1-9"><a name="ref1"></a>1<span class="htm-ref">.	</span>Ur E, Turner TH, Goodwin TJ, et al. Mania in association with hydrocortisone replacement for Addison’s disease. <span class="italic">Postgrad Med J</span>. 1992;68(795):41–43. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1561189&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1136/pgmj.68.795.41"><span class="pubmed-crossref">doi:10.1136/pgmj.68.795.41</span></a></p>
<p class="references-references-text-1-9"><a name="ref2"></a><span class="htm-ref"> 2.	</span>Kalambokis G, Konitsiotis S, Pappas D, et al. Akinetic mutism followed by a manic reaction on introduction of steroid replacement for Addison’s disease. <span class="italic">J Endocrinol Invest</span>. 2006;29(3):257–260. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16682841&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1007/BF03345550"><span class="pubmed-crossref">doi:10.1007/BF03345550</span></a></p>
<p class="references-references-text-1-9"><a name="ref3"></a><span class="htm-ref"> 3.	</span>Hunt PJ, Gurnell EM, Huppert FA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison’s disease in a randomized, double-blind trial. <span class="italic">J Clin Endocrinol Metab</span>. 2000;85(12):4650–4656. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11134123&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a></p>
<p class="references-references-text-1-9"><a name="ref4"></a><span class="htm-ref"> 4.	</span>Cleghorn RA. Adrenal cortical insufficiency: psychological and neurological observations. <span class="italic">Can Med Assoc J</span>. 1951;65(5):449–454. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14879326&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a></p>
<p class="references-references-text-1-9"><a name="ref5"></a><span class="htm-ref"> 5.	</span>Kaushik ML, Sharma RC. Addison’s disease presenting as depression. <span class="italic">Indian J Med Sci</span>. 2003;57(6):249–251. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14510342&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a></p>
<p class="references-references-text-1-9"><a name="ref6"></a><span class="htm-ref"> 6.	</span>Leigh H, Kramer SI. The psychiatric manifestations of endocrine disease. <span class="italic">Adv Intern Med</span>. 1984;29:413–445. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6369931&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a></p>
<p class="references-references-text-1-9"><a name="ref7"></a><span class="htm-ref"> 7.	</span>Fava GA, Sonino N, Morphy MA. Major depression associated with endocrine disease. <span class="italic">Psychiatr Dev</span>. 1987;5(4):321–348. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3328199&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a></p>
<p class="references-references-text-1-9"><a name="ref8"></a><span class="htm-ref"> 8.	</span>Thomsen AF, Kvist TK, Andersen PK, et al. The risk of affective disorders in patients with adrenocortical insufficiency. <span class="italic">Psychoneuroendocrinology</span>. 2006;31(5):614–622. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16545526&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1016/j.psyneuen.2006.01.003"><span class="pubmed-crossref">doi:10.1016/j.psyneuen.2006.01.003</span></a></p>
<p class="references-references-text-1-9"><a name="ref9"></a><span class="htm-ref"> 9.	</span>Anglin RE, Rosebush PI, Mazurek MF. The neuropsychiatric profile of Addison’s disease: revisiting a forgotten phenomenon. <span class="italic">J Neuropsychiatry Clin Neurosci</span>. 2006;18(4):450–459. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17135373&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1176/appi.neuropsych.18.4.450"><span class="pubmed-crossref">doi:10.1176/appi.neuropsych.18.4.450</span></a></p>
<p class="references-references-text-10-99"><a name="ref10"></a>10.	Iwata M, Hazama GI, Shirayama Y, et al. A case of Addison’s disease presented with depression as a first symptom. <span class="italic">Seishin Shinkeigaku Zasshi</span>. 2004;106(9):1110–1116. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15580869&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a></p>
<p class="references-references-text-10-99"><a name="ref11"></a>11.	Ten S, New M, Maclaren N. Clinical review 130: Addison’s disease 2001. <span class="italic">J Clin Endocrinol Metab</span>. 2001;86(7):2909–2922. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11443143&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a></p>
<p class="references-references-text-10-99"><a name="ref12"></a>12.	Sarkar SB, Sarkar S, Ghosh S, et al. Addison’s disease. <span class="italic">Contemp Clin Dent</span>. 2012;3(4):484–486. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23633816&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.4103/0976-237X.107450"><span class="pubmed-crossref">doi:10.4103/0976-237X.107450</span></a></p>
<p class="references-references-text-10-99"><a name="ref13"></a>13.	Kurland HD. Physiologic treatment of depressive reactions: a pilot study. <span class="italic">Am J Psychiatry</span>. 1965;122(4):457–458. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=5889791&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a></p>
<p class="references-references-text-10-99"><a name="ref14"></a>14.	Young EA, Lopez JF, Murphy-Weinberg V, et al. Mineralocorticoid receptor function in major depression. <span class="italic">Arch Gen Psychiatry</span>. 2003;60(1):24–28. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12511169&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1001/archpsyc.60.1.24"><span class="pubmed-crossref">doi:10.1001/archpsyc.60.1.24</span></a></p>
<p class="references-references-text-10-99"><a name="ref15"></a>15.	Moritz ML, Ayus JC. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. <span class="italic">Nephrol Dial Transplant</span>. 2003;18(12):2486–2491. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14605269&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1093/ndt/gfg394"><span class="pubmed-crossref">doi:10.1093/ndt/gfg394</span></a></p>
<p class="references-references-text-10-99"><a name="ref16"></a>16.	Squire LR, Zola-Morgan S. Memory: brain systems and behavior. <span class="italic">Trends Neurosci</span>. 1988;11(4):170–175. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2469186&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1016/0166-2236(88)90144-0"><span class="pubmed-crossref">doi:10.1016/0166-2236(88)90144-0</span></a></p>
<p class="references-references-text-10-99"><a name="ref17"></a>17.	Suzuki K, Awata S, Oyama Y, et al. Agitated depression successfully treated with electroconvulsive therapy combined with steroid cover in a patient with Addison’s disease. <span class="italic">Prog Neuropsychopharmacol Biol Psychiatry</span>. 2007;31(4):956–958. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17324493&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1016/j.pnpbp.2007.01.017"><span class="pubmed-crossref">doi:10.1016/j.pnpbp.2007.01.017</span></a></p>
<p class="references-references-text-10-99"><a name="ref18"></a>18.	Heijnen WT, Pluijms EM, Birkenhager TK. Refractory major depression successfully treated with electroconvulsive therapy in a patient with Addison’s disease. <span class="italic">J ECT</span>. 2013;29(2):137–138. <a href="
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23377750&dopt=Abstract"><span class="pubmed-crossref">PubMed</span></a> <a href="
http://dx.doi.org/10.1097/YCT.0b013e3182756695"><span class="pubmed-crossref">doi:10.1097/YCT.0b013e3182756695</span></a></p>
<p class="ltrs-br-ltr-br-body-text"> </p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Shinjini Kundu, MS</span></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Jodie Bryk, MD</span></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Abdulkader Alam, MD</span></p>
<p class="ltrs-br-ltr-br-author"><a href="
mailto:al.alam@stonybrookmedicine.edu"><span class="hyperlink">
al.alam@stonybrookmedicine.edu</span></a> </p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Author affiliations:</span> School of Medicine, University of Pittsburgh (all authors); Department of Biomedical Engineering, Carnegie Mellon University (Ms Kundu); Departments of General Internal Medicine (Dr Bryk) and Psychiatry (Dr Alam), University of Pittsburgh Medical Center; and Western Psychiatric Institute and Clinic (Dr Alam), Pittsburgh, Pennsylvania.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Potential conflicts of interest: </span>None reported.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Funding/support:</span> None reported.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Published online:</span> December 25, 2014.</p>
<p class="ltrs-br-ltr-br-copyright-doi"><span class="italic">Prim Care Companion CNS Disord 2014;16(6):</span><span class="doi">doi:10.4088/PCC.13l01578</span></p>
<p class="ltrs-br-ltr-br-copyright-doi"><span class="italic">© Copyright 2014 Physicians Postgraduate Press, Inc.</span></p>
</div>